Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
The Profile Study(Case Western Reserve University), Fredrick R. Schumacher(University of Cambridge), Australian Prostate Cancer BioResource (APCB)(National Cancer Institute), The IMPACT Study(University of Cambridge), Canary PASS Investigators(Institute of Cancer Research), Cancer of the Prostate in Sweden (CAPS)(Institute of Cancer Research), Ali Amin Al Olama(Institute of Cancer Research), Sonja I. Berndt(Institute of Cancer Research), Sara Benlloch(Institute of Cancer Research), Mahbubl Ahmed(Institute of Cancer Research), Edward J. Saunders(Institute of Cancer Research), Tokhir Dadaev(Institute of Cancer Research), Daniel Leongamornlert(University of Southern California), Ezequiel Anokian(Institute of Cancer Research), Clara Cieza-Borrella(Institute of Cancer Research), Chee Goh(Institute of Cancer Research), Mark N. Brook(Institute of Cancer Research), Xin Sheng(University of Southern California), Laura Fachal(American Cancer Society), Joe Dennis(American Cancer Society), Jonathan P. Tyrer(American Cancer Society), Kenneth Muir(Manchester Academic Health Science Centre), Artitaya Lophatananon(Manchester Academic Health Science Centre), Victoria L. Stevens(American Cancer Society), Susan M. Gapstur(American Cancer Society), Brian D. Carter(Griffith University), Catherine M. Tangen(Translational Research Institute), Phyllis J. Goodman(Translational Research Institute), Ian M. Thompson(Garvan Institute of Medical Research), Jyotsna Batra(Translational Research Institute), Suzanne K. Chambers(Griffith University), Leire Moya(Translational Research Institute), Judith A. Clements(Translational Research Institute), Lisa G. Horvath(Garvan Institute of Medical Research), Wayne D. Tilley(University of Cambridge), Gail P. Risbridger(University of Cambridge), Henrik Grönberg(University of Turku), Markus Aly(Karolinska University Hospital), Tobias Nordström(University of Turku), Paul D.P. Pharoah(Tampere University), Nora Pashayan(University of Cambridge), Johanna Schleutker(University of Turku), Teuvo L.J. Tammela(Karolinska Institutet), Csilla Sipeky(University of Turku), Anssi Auvinen(Tampere University), Demetrius Albanes(University of Cambridge), Stephanie J. Weinstein(University of Cambridge), Alicja Wolk(Uppsala University), Niclas Håkansson(Harvard University), Catharine West(Washington University in St. Louis), Alison M. Dunning(University of Cambridge), N.G. Burnet(University of Cambridge), Lorelei A. Mucci(Harvard University), Edward Giovannucci(Harvard University), Gerald L. Andriole(Washington University in St. Louis), Olivier Cussenot(Aarhus University Hospital), Géraldine Cancel‐Tassin(Aarhus University), Stella Koutros(Oslo University Hospital), Laura E. Beane Freeman(Oslo University Hospital), Karina D. Sørensen(Aarhus University), Torben F. Ørntoft(Aarhus University), Michael Borre(Aarhus University), Lovise Mæhle(Oslo University Hospital), Eli Marie Grindedal(Oslo University Hospital), David E. Neal(University of Cambridge), Jenny Donovan(Princess Margaret Cancer Centre), Freddie C. Hamdy(Princess Margaret Cancer Centre), Richard M. Martin(Princess Margaret Cancer Centre), Ruth C. Travis(University of Southern California), Timothy J. Key(University of Southern California), Robert J. Hamilton(Princess Margaret Cancer Centre), Neil E. Fleshner(Princess Margaret Cancer Centre), Antonio Finelli(Albert Einstein College of Medicine), Sue A. Ingles(University of Southern California), Mariana C. Stern(University of Southern California), Barry S. Rosenstein(Nanjing Medical University), Sarah L. Kerns(Queen Mary University of London), Harry Ostrer(Albert Einstein College of Medicine), Yong‐Jie Lu(Queen Mary University of London), Hong-Wei Zhang(Second Military Medical University), Ninghan Feng(Cancer Council Victoria), Xueying Mao(Queen Mary University of London), Xin Guo(Cancer Council Victoria), Guomin Wang(Cancer Council Victoria), Zan Sun(Brigham and Women's Hospital), Graham G. Giles(The University of Melbourne), Melissa C. Southey(Monash Health), Robert J. MacInnis(The University of Melbourne), Liesel M. FitzGerald(University of Tasmania), Adam S. Kibel(Brigham and Women's Hospital), Bettina F. Drake(Universitat Pompeu Fabra), Ana Vega(Fundación Pública Galega de Medicina Xenómica), Antonio Gómez‐Caamaño(Universitat Pompeu Fabra), Robert Szulkin(Brigham and Women's Hospital), Martin Eklund(Brigham and Women's Hospital), Manolis Kogevinas(Universitat Pompeu Fabra), Javier Llorca(Universidad de Cantabria), Gemma Castaño‐Vinyals(Universitat Pompeu Fabra), Kathryn L. Penney(Brigham and Women's Hospital), Meir J. Stampfer(Brigham and Women's Hospital), Jong Y. Park(Moffitt Cancer Center), Thomas A. Sellers(Moffitt Cancer Center), Hui‐Yi Lin(National Institutes of Health), Janet L. Stanford(University of Washington), Cezary Cybulski(University of Copenhagen), Dominika Wokołorczyk(University of Copenhagen), Jan Lubiński(Gentofte Hospital), Elaine A. Ostrander(National Institutes of Health), Milan S. Geybels(Copenhagen University Hospital), Børge G. Nordestgaard(University of Copenhagen), Sune F. Nielsen(University of Copenhagen), Maren Weischer(German Cancer Research Center), Rasmus Bisbjerg(Gentofte Hospital), Martin Andreas Røder(Copenhagen University Hospital), Peter Iversen(Copenhagen University Hospital), Hermann Brenner(German Cancer Research Center), Katarina Ćuk(The University of Texas MD Anderson Cancer Center), Bernd Holleczek(The University of Texas MD Anderson Cancer Center), Christiane Maier(Cancer Prevention Institute of California), Manuel Luedeke(Universidade do Porto), Thomas Schnoeller(Instituto Português de Oncologia Francisco Gentil), Jeri Kim(The University of Texas MD Anderson Cancer Center), Christopher J. Logothetis(The University of Texas MD Anderson Cancer Center), Esther M. John(Cancer Prevention Institute of California), Manuel R. Teixeira(Universidade do Porto), Paula Paulo(Ghent University), Marta Cardoso(Ghent University), Susan L. Neuhausen(Ghent University Hospital), Linda Steele(University of Malaya), Yuan Chun Ding(University of Malaya), Kim De Ruyck(Ghent University), Gert De Meerleer(Ghent University), Piet Ost(University of Washington), Azad Hassan Abdul Razack(Universität Hamburg), Jasmine Lim(University Hospital Centre Zagreb), Soo‐Hwang Teo(University Hospital Centre Zagreb), Daniel W. Lin(University of Washington), Lisa F. Newcomb(University of Alberta), Davor Lessel(University of Alberta), Marija Gamulin(University Hospital Centre Zagreb), Tomislav Kuliš(University Hospital Centre Zagreb), Radka Kaneva(University of Alberta), Nawaid Usmani(University of Alberta), Sandeep K. Singhal(University of Alberta), Chavdar Slavov(Medical University of Sofia), Vanio Mitev(Southampton General Hospital), Matthew Parliament(University of Alberta), Frank Claessens(University of Surrey), Steven Joniau(University of California San Diego), Thomas Van den Broeck(University Hospital Complex Of Vigo), Samantha Larkin(Southampton General Hospital), Paul A. Townsend(Erasmus MC), Claire Aukim-Hastie(Erasmus MC), Manuela Gago-Domínguez(Erasmus MC), Jose E. Castelao(Inserm), Marı́a Elena Martı́nez(Inserm), Monique J. Roobol(Inserm), Guido Jenster(NorthShore University HealthSystem), Ron H. N. van Schaik(University of Cambridge), F. Ménégaux(Inserm), Thérèse Truong(Inserm), Yves Akoli Koudou(Inserm), Jianfeng Xu(NorthShore University HealthSystem), Kay‐Tee Khaw(Mayo Clinic), Lisa Cannon‐Albright(Mayo Clinic), Hardev Pandha(University of Washington), Agnieszka Michael(Harvard University), Stephen N. Thibodeau(Brigham and Women's Hospital), Shannon K. McDonnell(Mayo Clinic), Daniel J. Schaid(Mayo Clinic), Sara Lindström(Queen Mary University of London), Constance Turman(Harvard University), Jing Ma(University of Hawaiʻi at Mānoa), David J. Hunter(University of Hawaiʻi at Mānoa), Elio Ríboli(National Cancer Institute), Afshan Siddiq(Queen Mary University of London), Federico Canzian(German Cancer Research Center), Laurence N. Kolonel(University of Hawaiʻi at Mānoa), Loı̈c Le Marchand(Dartmouth College), Robert N. Hoover(University of Southern California), Mitchell J. Machiela(University of Cambridge), Zuxi Cui(Karolinska Institutet), Peter Kraft(Harvard University), Christopher I. Amos(Dartmouth College), David V. Conti(University of Southern California), Douglas F. Easton(University of Southern California), Fredrik Wiklund(Royal Marsden NHS Foundation Trust), Stephen J. Chanock(National Cancer Institute), Brian E. Henderson(University of Southern California), Zsofia Kote‐Jarai(Institute of Cancer Research), Christopher A. Haiman(University of Southern California), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust)
Cited by 1,005Open Access
Abstract
Related Papers
Multiple newly identified loci associated with prostate cancer susceptibility
The UK Genetic Prostate Cancer Study Collaborators, Rosalind A. Eeles, The UK ProtecT Study Collaborators et al.|Nature Genetics|2008|849
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Rosalind A. Eeles, The Australian Prostate Cancer Bioresource, The UK ProtecT (Prostate testing for cancer and Treatment) Study Collaborators et al.|Nature Genetics|2013|550